LONDON/GENEVA (Reuters) – Drugmakers are looking for some kind of indemnity from governments or multilateral agencies for the widespread emergency use of new Ebola vaccines in Africa.
While the issue will not delay the industry’s ongoing work to accelerate production and clinical testing of three experimental vaccines, it is likely to be discussed at a high-level meeting in Geneva on Thursday.
GENEVA, Oct 21 (Reuters) – Tens of thousands of people in
West Africa are expected to begin getting experimental Ebola
vaccines from January, but population-wide immunisation is still
far off, the World Health Organization (WHO) said on Tuesday.
Initial clinical trials of vaccines from GlaxoSmithKline
and NewLink Genetics are already under way.
Some 500 volunteers are due to take part in countries including
the United States, Britain, Germany, Switzerland, Mali, Gabon
GENEVA (Reuters) – U.N. experts questioned Israeli officials on Monday over alleged rights abuses ranging from the demolition of Palestinian houses to mistreatment of detainees and limited Palestinian access to water.
Israel’s delegation defended its record before the United Nations Human Rights Committee, which examined respect for civil and political rights in Israel, the Gaza Strip and the West Bank. Each U.N. member state is reviewed every four years.
GENEVA (Reuters) – Top United Nations human rights official Zeid Ra’ad al-Hussein called on Monday for the release of Venezuelan opposition leader Leopoldo Lopez and scores of others detained in a crackdown on protests that began in February.
Zeid said in a statement issued after meeting Lopez’ wife Lilian Tintori in Geneva on Friday that the “prolonged and arbitrary detention” of political opponents and protesters was only exacerbating tensions in the oil-rich Andean country.
GENEVA (Reuters) – Food prices have risen by an average of 24 percent across the three countries worst hit by the Ebola outbreak, forcing some families to reduce their intake to one meal a day, the World Food Program (WFP) said on Friday.
The food-producing regions of Guinea, Sierra Leone and Liberia in West Africa have been severely affected by the worst outbreak on record of the viral hemorrhagic fever that has killed nearly 4,500 people.
GENEVA (Reuters) – The new United Nations human rights chief said on Thursday at his first media briefing in the job that he wanted to visit Tibet and was talking to Chinese authorities about a trip there.
More than 120 Tibetans, including many monks, have set themselves on fire since 2009 to protest against Beijing’s rule, which activists say tramples on religious freedom and culture.
DAKAR/GENEVA (Reuters) – In the first days of the Ebola outbreak in West Africa, as aid workers and health authorities battled to contain the deadly virus, Mariano Lugli asked himself a simple question: where was the World Health Organization?
Lugli, an Italian nurse, was among the first responders from medical charity Medecins Sans Frontieres (MSF) to reach the remote forests of Guinea in March where the hemorrhagic fever – one of the most lethal diseases known to man – was detected.
Islamic State insurgents in Iraq have carried out mass executions, abducted women and girls as sex slaves, and used child soldiers in what may amount to systematic war crimes that demand prosecution, the United Nations said on Thursday.
GENEVA (Reuters) – North Korea is ready to resume six-party talks on its nuclear program but must maintain its readiness in the face of joint U.S.-South Korean military exercises, a senior envoy in Geneva said on Thursday.
So Se Pyong, the Democratic People’s Republic of Korea’s (DPRK) ambassador to the United Nations in Geneva, told Reuters that his country was not planning a nuclear or missile test.
GENEVA (Reuters) – Both GlaxoSmithKline and NewLink Genetics are working to boost their capacity to make Ebola vaccines, with a goal of a “very significant increase in scale during the first half of 2015″, the World Health Organization said on Wednesday.
Even under the best conditions, if the experimental vaccines are proven to be safe and confer protection in clinical trials, a significant number of doses will not be available until late in the first quarter of 2015, the WHO said.